Hospital inpatient utilization of epoetin alfa (EPO) and darbepoetin alfa (DARB) in patients with cancer and pre-dialysis chronic kidney disease (PCKD)

被引：1
|
作者：
Smith, J
He, J
Mahoney, A
Noone, P
Watson, S
Mody, S
McKenzie, RS
机构：
[1] Solucient LLC, Berkeley Hts, NJ USA
[2] Ortho Biotech Prod LP, Bridgewater, NJ USA
[3] Ortho Biotech Clin Affairs LLC, Bridgewater, NJ USA
来源：
VALUE IN HEALTH | 2006年 / 9卷 / 03期
关键词：
D O I：
10.1016/S1098-3015(10)64632-3
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A105 / A105
页数：1
相关论文
共 50 条
  • [1] OBSERVATIONAL STUDY OF ANEMIC PATIENTS WITH PRE-DIALYSIS CHRONIC KIDNEY DISEASE (CKD) CONVERTING FROM DARBEPOETIN ALFA (DARB) TO EPOETIN ALFA (EPO)
    Lunde, Martin
    Jackson, James
    Lunacsek, Orsolya
    Bailey, Robert A.
    Senbetta, Mekre
    McKenzie, R. Scott
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2011, 57 (04) : A60 - A60
  • [2] HEMATOLOGIC OUTCOMES AND DOSING PATTERNS IN ANEMIC PATIENTS WITH PRE-DIALYSIS CHRONIC KIDNEY DISEASE (CKD) SWITCHING FROM DARBEPOETIN ALFA (DARB) TO EPOETIN ALFA (EPO)
    Hura, Claudia
    Jackson, James
    Lunacsek, Orsolya
    Bailey, Robert A.
    McKenzie, R. Scott
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2010, 55 (04) : A65 - A65
  • [3] Epoetin alfa and darbepoetin alfa dosing trends in pre-dialysis chronic kidney disease patients
    Mody, S
    Padmanabhan, V
    McKenzie, S
    Piech, CT
    [J]. VALUE IN HEALTH, 2005, 8 (03) : 416 - 416
  • [4] Epoetin alfa and darbepoetin alfa dosing patterns in anemic pre-dialysis chronic kidney disease patients
    Mody, S
    Padmanabhan, V
    McKenzie, RS
    Bookhart, B
    [J]. VALUE IN HEALTH, 2006, 9 (03) : A96 - A96
  • [5] Utilization of epoetin alfa (EPO) and darbepoetin alfa (DARB) in critically ill patients.
    Mody, S.
    Watson, S.
    McKenzie, R. S.
    Raut, M.
    [J]. CRITICAL CARE MEDICINE, 2006, 34 (12) : A131 - A131
  • [6] Comparison of epoetin alfa (EPO) and darbepoetin alfa (DARB) utilization in cancer chemotherapy patients treated in a hospital outpatient setting
    Vekeman, F.
    LaFeuille, M.
    Bailey, R.
    Piech, C. Tak
    McKenzie, R. S.
    Lefebvre, P.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [7] Epoetin alfa and darbepoetin alfa dosing patterns and drug costs in patients with pre-dialysis chronic kidney disease
    Lefevbre, P
    Mody, SH
    McKenzie, RS
    Bookhart, B
    Duh, MS
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2006, 47 (04) : A39 - A39
  • [8] Epoetin alfa and darbepoetin alfa dosing trends and drug costs in elderly pre-dialysis chronic kidney disease patients
    Mody, S.
    Padmanabhan, V
    Bookhart, B.
    Mckenzie, R. S.
    [J]. VALUE IN HEALTH, 2007, 10 (03) : A12 - A13
  • [9] EPOETIN ALFA (EPO) UTILIZATION TRENDS IN MEDICARE PATIENTS WITH CHRONIC KIDNEY DISEASE (CKD) NOT ON DIALYSIS
    Kokkotos, Fotios
    Bailey, Robert A.
    Kerr, Matthew
    Shen, Sherlynn
    Senbetta, Mekre
    McKenzie, R. Scott
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2010, 55 (04) : A41 - A41
  • [10] Alternate dosing strategies of epoetin alfa in pre-dialysis chronic kidney disease patients.
    Sarac, E
    Smavatkul, C
    Boolchand, V
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 : 794A - 794A
12345